Australia markets closed
  • ALL ORDS

    7,664.20
    -31.00 (-0.40%)
     
  • ASX 200

    7,392.60
    -24.80 (-0.33%)
     
  • AUD/USD

    0.7398
    +0.0000 (+0.00%)
     
  • OIL

    73.44
    -0.18 (-0.24%)
     
  • GOLD

    1,832.70
    -3.10 (-0.17%)
     
  • BTC-AUD

    53,709.78
    -509.95 (-0.94%)
     
  • CMC Crypto 200

    944.90
    +14.54 (+1.56%)
     
  • AUD/EUR

    0.6216
    -0.0002 (-0.03%)
     
  • AUD/NZD

    1.0546
    +0.0000 (+0.00%)
     
  • NZX 50

    12,594.52
    -134.33 (-1.06%)
     
  • NASDAQ

    15,048.36
    +30.26 (+0.20%)
     
  • FTSE

    7,024.55
    -53.87 (-0.76%)
     
  • Dow Jones

    35,084.53
    +153.60 (+0.44%)
     
  • DAX

    15,505.76
    -134.71 (-0.86%)
     
  • Hang Seng

    25,961.03
    -354.29 (-1.35%)
     
  • NIKKEI 225

    27,283.59
    -498.83 (-1.80%)
     

Extreme Tech Challenge Global Finals: Startup Pitches Part 2 - PathGen

PathGen Diagnostik Teknologi disrupts the molecular diagnostics market for cancer through inclusive, robust, and affordable platforms. With a strong ecosystem of academic-business-government-community partnership, PathGen seeks to democratize precision medicine, especially in developing countries, and enable molecular diagnostics for all.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting